Kolexia
Veyradier Agnes
Biologie médicale
Hôpital Lariboisière
Paris, France
246 Activités
7 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Purpura thrombotique thrombocytopénique Purpura Purpura thrombopénique Microangiopathies thrombotiques Syndrome hémolytique et urémique Thrombose Maladies de von Willebrand Purpura thrombopénique idiopathique Anémie hémolytique

Industries

Sanofi
25 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
20 collaboration(s)
Dernière en 2023
LFB
16 collaboration(s)
Dernière en 2023
WERFEN
2 collaboration(s)
Dernière en 2022

Dernières activités

Hemophagocytic lymphohistiocytosis is associated with deficiency and closed conformation of ADAMTS-13.
Research and practice in thrombosis and haemostasis   07 décembre 2023
Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience.
Blood advances   01 décembre 2023
Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trial.
Intensive care medicine   23 octobre 2023
Open ADAMTS13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura.
Journal of thrombosis and haemostasis : JTH   20 octobre 2023
Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura.
Journal of thrombosis and haemostasis : JTH   25 août 2023
Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay.
Research and practice in thrombosis and haemostasis   19 août 2023
The Metamorphosis, struggling to adapt to a new condition. The lived experience of patients with Thrombotic microangiopathies diagnosed in the ICU. A qualitative study.
Journal of critical care   13 juillet 2023
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Journal of neurology   01 juillet 2023
More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura.
Blood advances   19 juin 2023